How micro- and nanoplastics may worsen non-communicable diseases

FHS
June 21, 2024
2:48 pm

Researchers review and assess the potential exacerbation of non-communicable diseases by micro- and nanoplastics.

Tezepelumab by Amgen for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 18, 2024

First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which

September 19, 2023

Deeper Sedation During Colonoscopy Linked to Improved Detection of Serrated Polyps

Detection of serrated polyps during colonoscopy improved significantly with the use of propofol-based versus conventional sedation, data from a large registry showed. The detection rate

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.